News
News
- American Green, Inc. (OTC:ERBB) Issued Building Permit From the City of Phoenix for Its 40,000 SF Cannabis Grow Facility
01/11/2022 / 13:30 - GlobeNewswire - China's National Medical Products Administration Approves NUZYRA® (omadacycline) for the Treatment of Bacterial Pneumonia and Skin Infections
12/16/2021 / 17:36 - GlobeNewswire - Data from two Phase 3 studies demonstrating fitusiran significantly reduced bleeds in people with hemophilia A or B, with or without inhibitors, were featured at ASH’s plenary and late-breaking sessions
12/14/2021 / 15:00 - GlobeNewswire - Let's Glow SF Debuts in Downtown San Francisco as the Largest Holiday Projection Mapping Event in the U.S.
11/23/2021 / 19:00 - GlobeNewswire - Vivacitas Oncology, Inc. and Image Analysis Group to Present on AR-67 Clinical Response Evaluation at the Society for Neuro-Oncology Annual Conference
11/18/2021 / 14:00 - GlobeNewswire - Stifel Declares Quarterly Common Stock Cash Dividend and Declares Preferred Stock Cash Dividend
11/03/2021 / 21:15 - GlobeNewswire - IAMGOLD annonce le retour en sécurité de tout le personnel d'Essakane
11/01/2021 / 12:35 - Newsfile Corp - Oportun Completes $500 Million Asset-Backed Securitization
10/28/2021 / 22:05 - GlobeNewswire - Stifel Welcomes Lake Wealth Management Group, Opens Two New Offices in Missouri
10/21/2021 / 17:51 - GlobeNewswire - Paratek Pharmaceuticals Announces Enrollment of First Patient in Phase 2b Study Evaluating NUZYRA® (omadacycline) for Nontuberculous Mycobacterial (NTM) Pulmonary Disease Caused by Mycobacterium abscessus Complex (MABc)
10/18/2021 / 22:05 - GlobeNewswire
Real-time